Bio-Techne Corp
Ownership
Ownership Structure
Who owns Bio-Techne Corp (TECH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.6% of the shares are freely tradable; institutional investors hold 117.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 7.82 | 12,264,513 | +1.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 6.49 | 10,179,709 | +0.0 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 5.44 | 8,532,873 | +2.2 | 03/31/2026 |
| FMR Inc | 5.04 | 7,899,928 | +678.3 | 03/31/2026 |
| HBK INVESTMENTS L P | 4.35 | 6,825,000 | +0.0 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 4.13 | 6,480,337 | +0.0 | 03/31/2026 |
| State Street Corp | 3.74 | 5,868,396 | +1.0 | 03/31/2026 |
| Geode Capital Management, LLC | 3.26 | 5,112,420 | +3.7 | 03/31/2026 |
| Maverick Capital Ltd | 3.02 | 4,739,721 | +23.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.18 | 4,984,593 | +0.3 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Hippel James | CFO | 170,183 | 12,321,249 $ | Aug 15, 2026 | direct |
| Kelderman Kim | Chief Executive Officer | 82,762 | 5,991,969 $ | Aug 15, 2026 | direct |
| Geist William | PRESIDENT, PROTEIN SCIENCES | 24,943 | 1,805,873 $ | Aug 15, 2026 | direct |
| Bohnen Shane | SVP - General Counsel | 10,360 | 750,064 $ | Aug 15, 2026 | direct |
| Crouse Steven C. | President - Diag & Spatial Bi | 10,237 | 741,159 $ | Aug 15, 2026 | direct |
| Herr Amy E. | Director | 576 | 41,702 $ | Aug 15, 2026 | indirect |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 15, 2026 | Kelderman Kim | Chief Executive Officer | Other | 10,821 | 72.40 | 783,440 |
| Aug 15, 2026 | Kelderman Kim | Chief Executive Officer | Other | 21,470 | 0.00 | – |
| Aug 15, 2026 | Hippel James | CFO | Other | 4,310 | 72.40 | 312,044 |
| Aug 15, 2026 | Hippel James | CFO | Other | 9,779 | 0.00 | – |
| Aug 15, 2026 | Geist William | PRESIDENT, PROTEIN SCIENCES | Other | 1,976 | 72.40 | 143,062 |
| Aug 15, 2026 | Geist William | PRESIDENT, PROTEIN SCIENCES | Other | 6,416 | 0.00 | – |
| Aug 15, 2026 | Bohnen Shane | SVP - General Counsel | Other | 1,343 | 72.40 | 97,233 |
| Aug 15, 2026 | Bohnen Shane | SVP - General Counsel | Other | 4,350 | 0.00 | – |
| Aug 15, 2026 | Crouse Steven C. | President - Diag & Spatial Bi | Other | 1,947 | 72.40 | 140,963 |
| Aug 15, 2026 | Crouse Steven C. | President - Diag & Spatial Bi | Other | 5,423 | 0.00 | – |
| Aug 15, 2026 | Herr Amy E. | Director | Other | 213 | 72.40 | 15,421 |
| Aug 15, 2026 | Herr Amy E. | Director | Other | 589 | 0.00 | – |
| Jul 29, 2026 | Hippel James | CFO | Other | 51,024 | 72.03 | 3,675,259 |
| Jul 29, 2026 | Hippel James | CFO | Other | 62,068 | 47.60 | 2,954,437 |
| Jul 28, 2026 | Kelderman Kim | Chief Executive Officer | Other | 28,686 | 72.07 | 2,067,400 |
| Jul 28, 2026 | Kelderman Kim | Chief Executive Officer | Other | 35,000 | 47.60 | 1,666,000 |
| Jul 23, 2026 | Bohnen Shane | SVP - General Counsel | Other | 344 | 71.77 | 24,689 |
| Jul 23, 2026 | Bohnen Shane | SVP - General Counsel | Other | 448 | 47.60 | 21,325 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.